Who
Maggie Yuen
Director
Company insider
Files Form 4 as: Director, AtriCure; Chief Financial Officer, Penumbra.
In numbers
- Trades disclosed
- 59
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $4.0M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 16 Dec 2019
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $134K3,500 at $38.42 | filing |
| 5 Aug 2026filed 7 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $134K3,500 at $38.42 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code F | $63K186 at $336.18 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code F | $63K186 at $336.18 | filing |
| 2 Mar 2026filed 4 Mar 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Sold | $832K2,432 at $342.30 | filing |
| 2 Mar 2026filed 4 Mar 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Sold | $832K2,432 at $342.30 | filing |
| 17 Feb 2026filed 18 Feb 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code A | —2,630 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code A | —2,630 at $0.00 | filing |
| 15 Feb 2026filed 18 Feb 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code F | $163K481 at $339.30 | filing |
| 15 Feb 2026filed 18 Feb 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code F | $163K481 at $339.30 | filing |
| 13 Feb 2026filed 18 Feb 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code A | —2,630 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | PEN PenumbraMedical Devices | SEC FORM 4 Code A | —2,630 at $0.00 | filing |
| 15 Dec 2025filed 17 Dec 2025 | PEN PenumbraMedical Devices | SEC FORM 4 Code F | $175K565 at $309.15 | filing |
| 21 Nov 2025filed 25 Nov 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $107K3,000 at $35.72 | filing |
| 17 Nov 2025filed 18 Nov 2025 | PEN PenumbraMedical Devices | SEC FORM 4 Code A | —3,580 at $0.00 | filing |
| 15 Nov 2025filed 18 Nov 2025 | PEN PenumbraMedical Devices | SEC FORM 4 Code F | $102K364 at $280.07 | filing |
| 15 Nov 2025filed 18 Nov 2025 | PEN PenumbraMedical Devices | SEC FORM 4 Code F | $92K327 at $280.07 | filing |
| 15 Aug 2025filed 15 Aug 2025 | PEN Penumbraoption or derivative · Medical Devices | SEC FORM 4 Code M | —724 at $0.00 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Maggie Yuen; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.